257 related articles for article (PubMed ID: 16351509)
21. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora.
Rowland IR; Wiseman H; Sanders TA; Adlercreutz H; Bowey EA
Nutr Cancer; 2000; 36(1):27-32. PubMed ID: 10798213
[TBL] [Abstract][Full Text] [Related]
22. Dairy consumption is a significant correlate of urinary equol concentration in a representative sample of US adults.
Frankenfeld CL
Am J Clin Nutr; 2011 May; 93(5):1109-16. PubMed ID: 21389178
[TBL] [Abstract][Full Text] [Related]
23. Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore.
Seow A; Shi CY; Franke AA; Hankin JH; Lee HP; Yu MC
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):135-40. PubMed ID: 9488588
[TBL] [Abstract][Full Text] [Related]
24. Soy isoflavone intake and estrogen excretion patterns in young women: effect of probiotic administration.
Cohen LA; Crespin JS; Wolper C; Zang EA; Pittman B; Zhao Z; Holt PR
In Vivo; 2007; 21(3):507-12. PubMed ID: 17591361
[TBL] [Abstract][Full Text] [Related]
25. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans.
King RA; Bursill DB
Am J Clin Nutr; 1998 May; 67(5):867-72. PubMed ID: 9583843
[TBL] [Abstract][Full Text] [Related]
26. One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women.
Védrine N; Mathey J; Morand C; Brandolini M; Davicco MJ; Guy L; Rémésy C; Coxam V; Manach C
Eur J Clin Nutr; 2006 Sep; 60(9):1039-45. PubMed ID: 16482068
[TBL] [Abstract][Full Text] [Related]
27. Urinary excretion of equol by postmenopausal women consuming soymilk fermented by probiotic bifidobacteria.
Tsangalis D; Wilcox G; Shah NP; McGill AE; Stojanovska L
Eur J Clin Nutr; 2007 Mar; 61(3):438-41. PubMed ID: 17021598
[TBL] [Abstract][Full Text] [Related]
28. Distribution of isoflavones in samples of serum, liver and mammary glands of rats or pigs fed dietary isoflavones.
Gilani GS; Farmer C; Dyck M; Robertson P; Dahiya J; Sepehr E; Fan L; Nicolidakis H; Curran I; Cooke GM
Ann Nutr Metab; 2011; 58(3):171-80. PubMed ID: 21654164
[TBL] [Abstract][Full Text] [Related]
29. Urinary isoflavone kinetics: the effect of age, gender, food matrix and chemical composition.
Faughnan MS; Hawdon A; Ah-Singh E; Brown J; Millward DJ; Cassidy A
Br J Nutr; 2004 Apr; 91(4):567-74. PubMed ID: 15035683
[TBL] [Abstract][Full Text] [Related]
30. Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk.
Setchell KD; Brown NM; Zhao X; Lindley SL; Heubi JE; King EC; Messina MJ
Am J Clin Nutr; 2011 Nov; 94(5):1284-94. PubMed ID: 21955647
[TBL] [Abstract][Full Text] [Related]
31. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010).
North American Menopause Society
Menopause; 2011 Jul; 18(7):732-53. PubMed ID: 21685820
[TBL] [Abstract][Full Text] [Related]
32. Bioavailability and urinary excretion of isoflavones in humans: effects of soy-based supplements formulation and equol production.
Vergne S; Titier K; Bernard V; Asselineau J; Durand M; Lamothe V; Potier M; Perez P; Demotes-Mainard J; Chantre P; Moore N; Bennetau-Pelissero C; Sauvant P
J Pharm Biomed Anal; 2007 Mar; 43(4):1488-94. PubMed ID: 17110073
[TBL] [Abstract][Full Text] [Related]
33. Isoflavonoids do not inhibit in vivo lipid peroxidation in subjects with high-normal blood pressure.
Hodgson JM; Puddey IB; Croft KD; Mori TA; Rivera J; Beilin LJ
Atherosclerosis; 1999 Jul; 145(1):167-72. PubMed ID: 10428307
[TBL] [Abstract][Full Text] [Related]
34. Urinary equol excretion with a soy challenge: influence of habitual diet.
Lampe JW; Karr SC; Hutchins AM; Slavin JL
Proc Soc Exp Biol Med; 1998 Mar; 217(3):335-9. PubMed ID: 9492344
[TBL] [Abstract][Full Text] [Related]
35. Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products.
Hutchins AM; Slavin JL; Lampe JW
J Am Diet Assoc; 1995 May; 95(5):545-51. PubMed ID: 7722188
[TBL] [Abstract][Full Text] [Related]
36. Large inter-individual variation in isoflavone plasma concentration limits use of isoflavone intake data for risk assessment.
van der Velpen V; Hollman PC; van Nielen M; Schouten EG; Mensink M; Van't Veer P; Geelen A
Eur J Clin Nutr; 2014 Oct; 68(10):1141-7. PubMed ID: 24939433
[TBL] [Abstract][Full Text] [Related]
37. Influence of soybean processing, habitual diet, and soy dose on urinary isoflavonoid excretion.
Slavin JL; Karr SC; Hutchins AM; Lampe JW
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1492S-1495S. PubMed ID: 9848522
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the reliability of 24 h urine excretion as a biomarker of isoflavone exposure over time and over a wide range of isoflavone intakes.
Ritchie MR; Morton MS; Thompson AM; Deighton N; Blake A; Cummings JH; Steel CM
Eur J Clin Nutr; 2004 Sep; 58(9):1286-9. PubMed ID: 15054404
[TBL] [Abstract][Full Text] [Related]
39. Novel effects of phytoestrogenic soy isoflavones on serum calcium and chloride in premenopausal women: A 2-year double-blind, randomized, placebo-controlled study.
Lu LW; Chen NW; Nayeem F; Ramanujam VS; Kuo YF; Brunder DG; Nagamani M; Anderson KE
Clin Nutr; 2018 Dec; 37(6 Pt A):1862-1870. PubMed ID: 29183775
[TBL] [Abstract][Full Text] [Related]
40. Influence of soya-based infant formula consumption on isoflavone and gut microflora metabolite concentrations in urine and on faecal microflora composition and metabolic activity in infants and children.
Hoey L; Rowland IR; Lloyd AS; Clarke DB; Wiseman H
Br J Nutr; 2004 Apr; 91(4):607-16. PubMed ID: 15035688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
